🇺🇸 FDA
Patent

US 10851101

Compounds for treating spinal muscular atrophy

granted A61KA61K31/519A61P

Quick answer

US patent 10851101 (Compounds for treating spinal muscular atrophy) held by PTC THERAPEUTICS, INC. expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/519, A61P, A61P21/00, A61P25/00